Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Renal and metabolic outcomes after empagliflozin in cardiac surgery
2021-003172-13Phase 4Active
- Sponsor
- Amsterdam University Medical Center
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of empagliflozin in acute kidney failure (AKF) (2 arms), sponsored by Amsterdam University Medical Center. Started Oct 2021; status: active.
02
Drugs
empagliflozin
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on 2021-003172-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-003172-13.